Name: 글로벌 시장 동향
SKU: MD7846
Availability: InStock

보고서 요약(국문)

개요
전 세계 말초혈관 중재술 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 보이며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
말초혈관 중재술은 심장과 뇌를 제외한 신체의 말초혈관계(동맥과 정맥)에 영향을 미치는 질환에 대한 치료를 의미합니다. 심부정맥혈전증(DVT), 말초동맥질환(PAD) 및 기타 혈관 질환은 이러한 시술을 통해 흔히 치료됩니다.
최소침습 시술 및 개선된 스텐트 설계와 같은 의료기기 기술의 발전으로 치료 가능한 질환의 범위가 확대되었고, 시술의 안전성과 효과가 향상되었습니다. 말초동맥질환 및 심부정맥혈전증과 같은 질환의 유병률 증가가 이 시장 성장에 기여하고 있습니다.

시장 동향: 주요 동인
말초동맥질환(PAD) 유병률 증가
2022년 라이프 저널에 따르면, 유럽 지역의 PAD 유병률이 7.99%로 가장 높았으며, 45~54세 연령층에서 높은 발병률을 보였습니다. 아프리카 지역의 유병률은 4.06%로 가장 낮았습니다. 전 세계 PAD 유병률의 68% 이상은 15개국에서 집계되었으며, 중국, 인도, 미국에서 가장 많은 환자가 보고되었습니다.
2020년 한 국제기구에 따르면, 인도에서는 4,100만~5,400만 명이 PAD를 앓고 있는 것으로 추정됩니다. 또한 420만~620만 명이 중증 사지 허혈을 겪고 있습니다. 제2형 당뇨병, 흡연, 고콜레스테롤혈증은 동맥에 플라크가 축적되어 PAD를 유발하는 주요 원인입니다.

말초동맥질환(PAD)의 경우, 엘루비아 약물 방출 스텐트와 레인저 약물 코팅 풍선은 1단계 무작위 대조 시험(RCT)을 통해 효능이 입증된 최초의 기기입니다. 보스턴 사이언티픽은 두 가지 약물 방출 PAD 치료 옵션을 제공하며, 각각 직접 비교 효능 시험을 통해 효능이 입증되었습니다. 의료 전문가는 환자의 필요와 병변의 특성을 고려하여 치료 방침을 결정합니다.
규제 문제
엄격한 법적 지침과 의료기기에 대한 장기간의 승인 절차로 인해 새로운 혁신 기술과 제품을 시장에 출시하는 것이 더욱 어려워질 수 있습니다. 특정 환자 집단의 경우, 일부 말초혈관 치료법 및 관련 기기의 높은 비용으로 인해 사용이 제한될 수 있습니다. 모든 의료 시술에는 위험이 따르며, 환자는 여러 가지 문제로 인해 말초혈관 시술을 받지 않기로 결정할 수 있습니다. 일부 지역에서는 혈관 질환 및 조기 개입의 중요성에 대한 지식이 여전히 부족할 가능성이 있습니다.
세분화 분석
전 세계 말초혈관 시술 시장은 제품 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.

가이드 와이어 부문은 시장 점유율의 약 56.7%를 차지했습니다.
가이드 와이어는 혈관 및 중재 시술에서 필수적인 기구이며, 말초 혈관 중재 시술에 자주 사용됩니다. 가이드 와이어라고 불리는 가늘고 유연한 와이어는 카테터의 위치를 잡고, 순환계를 통과하며, 다양한 의료 용품이나 치료제를 전달할 경로를 만드는 데 사용됩니다.
메드트로닉은 다양한 길이, 팁 구성, 지지 수준 및 유연성을 제공하는 Wholey 가이드 와이어 시스템을 통해 까다로운 상황에서도 시술이 가능하도록 지원합니다. 이 제품은 고유한 사전 코팅 기술 덕분에 코일 전체에 균일한 코팅이 적용되어 중재 시술 기기와의 더욱 원활한 인터페이스를 제공합니다.
Nitrex 가이드 와이어를 선택하면 니티놀 가이드 와이어의 탁월한 성능을 경험할 수 있습니다. 가시성이 뛰어나고 외상이 적은 금 텅스텐 팁과 니티놀 코어가 결합되어 복잡한 해부학적 구조와 까다로운 병변을 쉽게 통과할 수 있습니다. 다양한 팁 모양과 스타일의 Nitrex 가이드와이어를 사용하여 시술 요구 사항에 맞춰 선택할 수 있습니다.
지역 분석
북미는 시장 점유율의 약 41.4%를 차지했습니다.
북미는 전 세계 말초혈관 중재 시술 시장에서 지배적인 위치를 차지하고 있습니다. 미국 질병통제예방센터(CDC)에 따르면, 말초동맥질환(PAD)은 심장에서 하지로 혈액을 운반하는 동맥이 좁아지거나 막히는 질환입니다.
미국에서는 40세 이상 성인 약 650만 명이 PAD를 앓고 있으며, 이는 대부분 동맥경화증, 즉 동맥에 지방 플라크가 축적되는 것으로 인해 발생합니다. 흑인 또는 히스패닉 환자의 PAD 발병률은 백인 환자와 비슷하거나 다소 높을 수 있습니다.
PAD의 유병률은 진단 기준에 따라 달라지는데, 증상이 있는 환자만 포함할 경우 질병 부담을 과소평가하는 경우가 흔합니다. 70세 이상 성인에서 말초동맥질환(PAD) 발병률이 가장 높으며, 연령이 증가함에 따라 발병률도 급격히 증가합니다.4, 5 미국에서는 전체 인구의 1.3%가 중증 사지 허혈(CLI) 또는 만성 사지 위협 허혈(CLTI)과 관련된 심각한 PAD를 앓고 있으며, 이는 절단으로 이어질 수 있습니다.
COVID-19 영향 분석
2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 전 세계 말초혈관 시술 시장에 전례 없는 어려움을 초래했습니다. 의료 자원을 절약하고 바이러스 전파 가능성을 낮추기 위해 팬데믹 초기에는 일부 말초혈관 시술을 포함한 많은 비응급 의료 시술이 연기되거나 지연되었습니다. 그 결과 시술 건수가 일시적으로 감소했습니다.
일부 사람들은 병원에서 COVID-19에 감염될 것을 우려하여 의료 서비스를 받는 것을 꺼리거나 미뤘습니다. 이는 특히 비응급 사례에서 두드러지게 나타났기 때문에 말초혈관 시술 환자 수에 영향을 미쳤을 수 있습니다.

제품 유형별
• 카테터
• 시스
• 스텐트
• 가이드 와이어
• 죽상동맥경화 제거 장치
• 색전 장치
• 혈전 제거 장치
• 하대정맥 필터
• 기타
적용 분야별
• 말초동맥질환
• 정맥혈전색전증
• 기타
최종 사용자별
• 병원
• 심혈관 조영술실
• 외래 수술 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Angioscore Ltd., Cordis Corp., Boston Scientific, Cook 등이 있습니다. 주요 기업으로는 Medtronic Inc., Volcano Corporation, Terumo Interventional Systems Inc., Teleflex Medical, Edward Lifesciences 등이 있습니다.

주요 동향
• 2021년 9월, Abbott는 말초 혈전 제거를 위한 최소 침습 기계식 흡인 혈전 제거 시스템을 개발한 상용화 단계의 의료기기 회사인 Walk Vascular, LLC를 인수했습니다.

보고서 구매 이유

• 제품 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 말초 혈관 중재 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위해

• 트렌드 및 공동 개발 분석을 통해 사업 기회를 식별하기 위해

• 모든 세그먼트를 포함한 말초 혈관 중재 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서

• 주요 기업의 핵심 제품 목록이 담긴 Excel 파일 제공 글로벌 말초혈관 중재시술 시장 보고서는 약 61개의 표, 64개의 그림, 그리고 186페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The Global Peripheral Interventions Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
Peripheral interventions refres to treatments for ailments affecting the body's peripheral vascular system, which consists of arteries and veins outside the heart and brain. Conditions like deep vein thrombosis (DVT), peripheral artery disease (PAD), and other vascular illnesses are frequently treated using these techniques and technologies.
Developments in medical device technologies, such as minimally invasive procedures and improved stent designs, have expanded the range of treatable conditions and made interventions safer and more effective. The growing prevalence of diseases like peripheral artery disease and deep vein thrombosis has contributed to the growth of this market.
Market Dynamics: Drivers
The Increasing Prevalence of Peripheral Artery Disease
According to Life Journal in 2022, The European Region had the highest prevalence of PAD (7.99%), with the age range of 45–54 years old accounting for the majority of the high case numbers. The African region has the lowest prevalence (4.06%). More than two-thirds (68%) of the global prevalence was represented by case counts from fifteen nations, with China, India, and the United States reporting the greatest case numbers.
According to an International organization in 2020, It is estimated that between 41 and 54 million people in India suffer from peripheral artery disease. Between 4.2 and 6.2 million people suffer from critical limb ischemia. Type 2 diabetes, smoking, and hypercholesterolemia are the main causes of PAD because they cause plaque to accumulate in the arteries.
For peripheral artery disease (PAD), the Eluvia Drug-Eluting Stent and the Ranger Drug-Coated Balloon are the first devices supported by level-one randomized controlled trials (RCTs). Boston Scientific provides two drug-eluting PAD options, each supported by comparative efficacy head-to-head trials. Medical professionals select the course of action based on the patient's needs and the lesion.
Regulatory Challenges
Strict legal guidelines and lengthy approval procedures for medical devices might make it more difficult to bring new innovations and goods to market. For particular patient populations, the high cost of some peripheral therapies and related devices may prevent them from being used. Every medical operation carries some risk, and patients may decide not to undergo peripheral interventions due to problems. It's possible that knowledge concerning vascular illnesses and the value of early intervention is still lacking in some areas.
Segment Analysis
The global peripheral interventions market is segmented based on product type, application, end-user and region.
The guide wires segment accounted for approximately 56.7% of the market share
Guidewires are vital instruments in vascular and interventional operations, and they are frequently used in peripheral interventions. Thin, flexible wires called guidewires are used to position catheters, navigate through the circulatory system, and create a pathway for the delivery of various medical supplies or therapies.
Medtronic offers The Wholey guidewire system, which comes in a range of lengths, tip configurations, levels of support, and flexibility, can be used to navigate difficult instances. A uniform coating is applied across the coil thanks to the device's unique precoating technique, which facilitates a more seamless interface with interventional devices.
Selecting Nitrex guidewires will allow you to enjoy remarkable performance in a nitinol guidewire. The highly visible, atraumatic gold tungsten tip of the guidewire combined with its nitinol core makes it easy to navigate complex anatomy and tough lesions. Different tip shapes and styles of Nitrex guidewires are available to match your procedural demands..
Geographical Analysis
North America accounted for approximately 41.4% of the market share
North America has been a dominant force in the global peripheral interventions market. According to the Centers for Disease Control and Prevention (CDC), the disorder known as peripheral arterial disease (PAD) is defined by the constriction or obstruction of the blood arteries that carry blood from the heart to the lower limbs.
About 6.5 million adults over 40 in the US suffer from PAD, which is mostly brought on by atherosclerosis, or the accumulation of fatty plaque in the arteries. Patients who identify as Black or Hispanic may experience PAD at rates that are comparable to or somewhat greater than those of White patients.
The prevalence of PAD varies depending on criteria, as it is common to underestimate the disease burden when only symptomatic patients are included. Adults over 70 years of age have the highest frequency of PAD, with rates rising quickly with age.4. 5 In the US, 1.3% of individuals suffer from severe PAD associated with critical limb ischemia (CLI) or chronic limb-threatening ischemia (CLTI), which can result in amputation.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global peripheral interventions market. Many non-urgent medical operations, including some peripheral interventions, were postponed or delayed during the early stages of the pandemic in order to conserve healthcare resources and lower the possibility of viral transmission. The number of procedures temporarily decreased as a result of this.
Certain people avoided or delayed obtaining medical attention because to their fear of catching COVID-19 in hospital environments. This may have an effect on the patient pool for peripheral procedures because it was particularly true for less urgent cases.
By Product Type
• Catheters
• Sheath
• Stents
• Guide Wires
• Atherectomy Devices
• Embolic Devices
• Thrombectomy Devices
• IVC Filters
• Others
By Application
• Peripheral Artery Disease
• Venous Thromboembolism
• Others
By End-User
• Hospitals
• Catheterization Laboratories
• Ambulatory Surgical Centres
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Angioscore Ltd., Cordis Corp., Boston Scientific, Cook Medical, Medtronic Inc., Volcano Corporation, Terumo Interventional Systems Inc., Teleflex Medical, Edward Lifesciences among others.
Key Developments
• In September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device organization with a minimally invasive mechanical aspiration thrombectomy system developed to remove peripheral blood clots.
Why Purchase the Report?
• To visualize the global peripheral interventions market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of peripheral interventions market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global peripheral interventions market report would provide approximately 61 tables, 64 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Prevalence of Peripheral Artery Disease
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Regulatory Challenges
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Catheters*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sheath
7.4. Stents
7.5. Guide Wires
7.6. Atherectomy Devices
7.7. Embolic Devices
7.8. Thrombectomy Devices
7.9. IVC Filters
7.10. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Peripheral Artery Disease*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Venous Thromboembolism
8.4. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Catheterization Laboratories*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centres
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Abbott Vascular*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Angioscore Ltd.
12.3. Cordis Corp.
12.4. Boston Scientific
12.5. Cook Medical
12.6. Medtronic Inc.
12.7. Volcano Corporation
12.8. Terumo Interventional Systems Inc.
12.9. Teleflex Medical
12.10. Edward Lifesciences
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Abbott Vascular, 4.	Key Developments, Angioscore Ltd., Cordis Corp., Boston Scientific, Cook Medical, Medtronic Inc., Volcano Corporation, Terumo Interventional Systems Inc., Teleflex Medical, Edward Lifesciences

표 목록 (Tables)

List of Tables

Table 1 Global Peripheral Interventions Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 2 Global Peripheral Interventions Market Value, By Intervention Type, 2025, 2029 & 2033 (US$ Billion)

Table 3 Global Peripheral Interventions Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 4 Global Peripheral Interventions Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 5 Global Peripheral Interventions Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 6 Global Peripheral Interventions Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)

Table 7 Global Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 8 Global Peripheral Interventions Market Value, By Intervention Type, 2025, 2029 & 2033 (US$ Billion)

Table 9 Global Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)

Table 10 Global Peripheral Interventions Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)

Table 11 Global Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)

Table 12 Global Peripheral Interventions Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)

Table 13 Global Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)

Table 14 Global Peripheral Interventions Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)

Table 15 Global Peripheral Interventions Market Value, By Region, 2022-2033 (US$ Billion)

Table 16 North America Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 17 North America Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)

Table 18 North America Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)

Table 19 North America Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)

Table 20 North America Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)

Table 21 Asia-Pacific Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 22 Asia-Pacific Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)

Table 23 Asia-Pacific Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)

Table 24 Asia-Pacific Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)

Table 25 Asia-Pacific Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)

Table 26 Europe Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 27 Europe Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)

Table 28 Europe Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)

Table 29 Europe Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)

Table 30 Europe Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)

Table 31 South America Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 32 South America Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)

Table 33 South America Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)

Table 34 South America Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)

Table 35 South America Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)

Table 36 Middle East and Africa Peripheral Interventions Market Value, By Product Type, 2022-2033 (US$ Billion)

Table 37 Middle East and Africa Peripheral Interventions Market Value, By Intervention Type, 2022-2033 (US$ Billion)

Table 38 Middle East and Africa Peripheral Interventions Market Value, By Application, 2022-2033 (US$ Billion)

Table 39 Middle East and Africa Peripheral Interventions Market Value, By End-User, 2022-2033 (US$ Billion)

Table 40 Middle East and Africa Peripheral Interventions Market Value, By Country, 2022-2033 (US$ Billion)

Table 41 Boston Scientific Corporation: Overview

Table 42 Boston Scientific Corporation: Product Portfolio

Table 43 Boston Scientific Corporation: Key Developments

Table 44 Medtronic: Overview

Table 45 Medtronic: Product Portfolio

Table 46 Medtronic: Key Developments

Table 47 Abbott: Overview

Table 48 Abbott: Product Portfolio

Table 49 Abbott: Key Developments

Table 50 Terumo Corporation: Overview

Table 51 Terumo Corporation: Product Portfolio

Table 52 Terumo Corporation: Key Developments

Table 53 Cook: Overview

Table 54 Cook: Product Portfolio

Table 55 Cook: Key Developments

Table 56 B. Braun SE: Overview

Table 57 B. Braun SE: Product Portfolio

Table 58 B. Braun SE: Key Developments

Table 59 BD: Overview

Table 60 BD: Product Portfolio

Table 61 BD: Key Developments

Table 62 Cordis: Overview

Table 63 Cordis: Product Portfolio

Table 64 Cordis: Key Developments

Table 65 Biotronik: Overview

Table 66 Biotronik: Product Portfolio

Table 67 Biotronik: Key Developments

Table 68 W. L. Gore & Associates, Inc.: Overview

Table 69 W. L. Gore & Associates, Inc.: Product Portfolio

Table 70 W. L. Gore & Associates, Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 2 Global Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)

Figure 4 Global Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)

Figure 5 Global Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)

Figure 6 Global Peripheral Interventions Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Peripheral Interventions Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 8 Stents Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 9 Angioplasty Balloons Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 10 Catheters & Sheaths Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 11 Guide Wires Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 12 Atherectomy Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 13 Embolic / Embolization Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 14 Thrombectomy Devices Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 15 Inferior Vena Cava (IVC) Filters Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 16 Other Devices & Accessories Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 17 Global Peripheral Interventions Market Y-o-Y Growth, By Intervention Type, 2023-2033 (%)

Figure 18 Atherectomy Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 19 Stent Implantation Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 20 Angioplasty Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 21 Thrombectomy Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 22 Embolization Intervention Type in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 23 Global Peripheral Interventions Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 24 Peripheral Artery Disease Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 25 Venous Thromboembolism Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 26 Others Application in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 27 Global Peripheral Interventions Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 28 Hospitals End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 29 ASCs End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 30 Cath Labs/Specialty Clinics End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 31 Other End-User in Global Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 32 Global Peripheral Interventions Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 33 North America Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 34 North America Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)

Figure 35 North America Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)

Figure 36 North America Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)

Figure 37 North America Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)

Figure 38 North America Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)

Figure 39 Asia-Pacific Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 40 Asia-Pacific Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)

Figure 41 Asia-Pacific Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)

Figure 42 Asia-Pacific Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)

Figure 43 Asia-Pacific Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)

Figure 44 Asia-Pacific Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)

Figure 45 Europe Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 46 Europe Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)

Figure 47 Europe Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)

Figure 48 Europe Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)

Figure 49 Europe Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)

Figure 50 Europe Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)

Figure 51 South America Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 52 South America Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)

Figure 53 South America Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)

Figure 54 South America Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)

Figure 55 South America Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)

Figure 56 South America Peripheral Interventions Market Share, By Country, 2024 & 2033 (%)

Figure 57 Middle East and Africa Peripheral Interventions Market Value, 2022-2033 (US$ Billion)

Figure 58 Middle East and Africa Peripheral Interventions Market Share, By Product Type, 2024 & 2033 (%)

Figure 59 Middle East and Africa Peripheral Interventions Market Share, By Intervention Type, 2024 & 2033 (%)

Figure 60 Middle East and Africa Peripheral Interventions Market Share, By Application, 2024 & 2033 (%)

Figure 61 Middle East and Africa Peripheral Interventions Market Share, By End-User, 2024 & 2033 (%)

Figure 62 Boston Scientific Corporation: Financials

Figure 63 Medtronic: Financials

Figure 64 Abbott: Financials

Figure 65 Terumo Corporation: Financials

Figure 66 Cook: Financials

Figure 67 B. Braun SE: Financials

Figure 68 BD: Financials

Figure 69 Cordis: Financials

Figure 70 Biotronik: Financials

Figure 71 W. L. Gore & Associates, Inc.: Financials

글로벌 말초혈관 중재시술 시장 – 2023-2030

Global Peripheral Interventions Market - 2023-2030